Medi Assist Healthcare Services Limited has informed the Exchange about Transcript
MEDIASSIST · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi Assist reported a strong Q3 FY26 with consolidated revenue growth of 24% for 9 months and a 154 basis points quarter-on-quarter EBITDA margin expansion to 18.6% (21.8% ex-Paramount). Total premiums under management grew 21.9% YoY to INR19,289 crore, pushing overall market share to 21.1% and group market share to 32.2%. The company became debt-free in January 2026 after repaying the remaining INR39.4 crore, with a free cash position of INR200 crore. Tech revenues grew 81.5% YoY, and AI-led fraud detection tool MAven Guard prevented INR400 crore of fraud. Paramount integration is on track, with a slump transfer to Medi Assist TPA effective February 1, 2026, and Paramount's EBITDA margins improved 557 bps QoY. Reported PAT of INR34.8 crore was dragged by three exceptional items totalling ~INR14.2 crore (cybersecurity incident at Paramount, labour code impact, and a claim-related provision), with underlying PAT estimated at INR76.7 crore. Retail premiums remained sluggish, growing only 4.6% including Paramount.
Positive for shareholders — strong revenue growth, margin expansion, and a debt-free, cash-rich balance sheet strengthen the company's financial position. The Paramount turnaround and tech revenue ramp-up are encouraging, though weak retail growth and one-time exceptional costs may cap near-term upside.